Phenogenetic HIV Negative

  • Principal Investigator(s): Philip De Jager
  • Study Contact: Laura Glick, 617-264-5947; lglick@partners.org   or   Tina Xue, txue@partners.org
  • Description of Subjects: Self reported healthy, 18+, recallable for blood draw based on phenotype and genotype
  • Location (Domestic vs. International): Domestic
  • Enrollment Period: 2006 - ongoing
  • Current Accrued Enrollment: 1753 current participants in the study
  • Enrollment Goal: Planning to recruit 500 new participants every 5 years in order to sustain the subject population
  • Key Exclusion and Inclusion Criteria: Inclusion: healthy individual, no history of autoimmune disorders, 18+
  • Available Biological Specimens and Data: fresh blood samples, frozen serum, plasma, pbmc, dna for most
  • How to Request Access: mailto:genestudy@partners.org
  • Link to Cohort Website: http://dejager_lab.bwh.harvard.edu/?page_id=2317
See also: Blood, serum, and plasma, DNA, Peripheral Blood Mononuclear Cells, HIV-, Brigham and Women's Hospital, Studies > 1000 Participants, Studies Started Post-2005, Domestic, Philip De Jager